BOCA RATON, Fla., March 23, 2018 -- The Law Firm of Klayman & Toskes, P.A., www.nasd-law.com issues an important notice to all customers who have purchased vehicles or serviced vehicles at Ferrari-Maserati of Fort Lauderdale. The firm is interested in speaking with customers who purchased or serviced their vehicles at Ferrari-Maserati of Fort Lauderdale in the last five years. Please contact Klayman & Toskes, P.A. toll free at (888) 997-9956 and visit the firm’s website at: www.nasd-law.com.
About Klayman & Toskes, P.A.
K&T is a national law firm which represents plaintiffs throughout the world in large and complex litigation matters including class actions. K&T has office locations in California, Florida, New York and Puerto Rico.
Contact:
Klayman & Toskes, PA
888-997-9956
www.nasd-law.com


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



